EA201890886A1 - Композиция для отбеливания кожи - Google Patents

Композиция для отбеливания кожи

Info

Publication number
EA201890886A1
EA201890886A1 EA201890886A EA201890886A EA201890886A1 EA 201890886 A1 EA201890886 A1 EA 201890886A1 EA 201890886 A EA201890886 A EA 201890886A EA 201890886 A EA201890886 A EA 201890886A EA 201890886 A1 EA201890886 A1 EA 201890886A1
Authority
EA
Eurasian Patent Office
Prior art keywords
niacinamide
composition
melanocytes
transfer
skin whitening
Prior art date
Application number
EA201890886A
Other languages
English (en)
Other versions
EA035440B1 (ru
Inventor
Анита Дамодаран
Маной Кумар Джоши
Балу Кунджупиллай
Резван Шарифф
Original Assignee
Юнилевер Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнилевер Н.В. filed Critical Юнилевер Н.В.
Publication of EA201890886A1 publication Critical patent/EA201890886A1/ru
Publication of EA035440B1 publication Critical patent/EA035440B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к области композиций для ухода за собой, в частности композиций для отбеливания кожи. Полагают, что ниацинамид снижает перенос меланосом из меланоцитов в кератиноциты, причем посредством этого вызывается отбеливание кожи. Однако известно, что ниацинамид не оказывает или оказывает слабое действие непосредственно на содержание меланина в меланоцитах. Таким образом, остается потребность в композиции с несколькими типами действия, в которой объединяется снижение переноса меланосом и снижение содержания меланина в меланоцитах. Поэтому целью настоящего изобретения является композиция с синергетическими количествами пиколинамида и ниацинамида, обеспечивающая улучшенное ингибирование переноса меланосом. Было обнаружено, что синергетическое действие отбеливания кожи получают, когда ниацинамид комбинируют с его изомером пиколинамидом.
EA201890886A 2015-10-05 2016-10-04 Композиция для осветления кожи EA035440B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15188360 2015-10-05
PCT/EP2016/073617 WO2017060211A1 (en) 2015-10-05 2016-10-04 A skin lightening composition

Publications (2)

Publication Number Publication Date
EA201890886A1 true EA201890886A1 (ru) 2018-09-28
EA035440B1 EA035440B1 (ru) 2020-06-15

Family

ID=54256684

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201890886A EA035440B1 (ru) 2015-10-05 2016-10-04 Композиция для осветления кожи
EA201890889A EA035789B1 (ru) 2015-10-05 2016-10-04 Композиция, содержащая ниацинамид и пиколинамид

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201890889A EA035789B1 (ru) 2015-10-05 2016-10-04 Композиция, содержащая ниацинамид и пиколинамид

Country Status (13)

Country Link
US (3) US10952952B2 (ru)
EP (2) EP3359261B1 (ru)
JP (2) JP6880011B2 (ru)
KR (1) KR102643373B1 (ru)
CN (2) CN108136232B (ru)
AR (1) AR106261A1 (ru)
BR (1) BR112018005742B1 (ru)
CA (2) CA3000880A1 (ru)
EA (2) EA035440B1 (ru)
MX (2) MX365369B (ru)
PH (1) PH12018500619B1 (ru)
WO (2) WO2017060211A1 (ru)
ZA (2) ZA201802005B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6880011B2 (ja) 2015-10-05 2021-06-02 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚美白組成物
WO2019121529A1 (en) 2017-12-18 2019-06-27 Unilever N.V. A topical composition
US20220362127A1 (en) * 2019-07-12 2022-11-17 Conopco, Inc., D/B/A Unilever Bioenergetic combinations and methods of using same
WO2021249760A1 (en) * 2020-06-10 2021-12-16 Unilever Ip Holdings B.V. A cosmetic composition comprising 6-methyl-picolinamide
US11696889B2 (en) 2020-08-07 2023-07-11 David Levy Botanical antimicrobial composition
WO2023175061A1 (en) * 2022-03-18 2023-09-21 Unilever Ip Holdings B.V. A skin brightening composition

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1370236A (en) * 1972-01-11 1974-10-16 Unilever Ltd Skin composition
GB1533119A (en) * 1975-04-10 1978-11-22 Unilever Ltd Skin lightening compositions
GB8910366D0 (en) * 1989-05-05 1989-06-21 Unilever Plc Skin composition
TW233264B (ru) 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
WO1999047141A1 (en) 1998-03-16 1999-09-23 The Procter & Gamble Company Method of treating skin irritation
JP2003529590A (ja) 2000-03-21 2003-10-07 アスション デヴェロップメント エーピーエス ピリジンカルボキシ誘導体およびｈ２ヒスタミン受容体アンタゴニストからなる化学的複合体
US20030105034A1 (en) 2001-07-05 2003-06-05 Astion Deveopment A/S Pyridine carboxy derivatives and an aminosugar
FR2827763B1 (fr) 2001-07-24 2005-09-23 Cs Substance alkyloside inhibant la fixation de microorganismes, utilisation topique et composition contenant au moins une telle substance
JP3908969B2 (ja) 2002-03-18 2007-04-25 ピアス株式会社 化粧料
JP4589721B2 (ja) 2002-06-20 2010-12-01 アスティオン デルマトロジー エイ／エス ポリヒドロキシアルカンの脂肪酸エステルおよびピリジンカルボキシ誘導体の新規複合体
JP2004123554A (ja) * 2002-09-30 2004-04-22 Pias Arise Kk 皮膚バリア機能改善物質、皮膚のしわ改善物質、および該物質を含む皮膚外用剤、化粧料および医薬部外品
US20090105188A1 (en) * 2007-10-17 2009-04-23 Nationwide Children's Hospital, Inc. Compositions and Methods for Treating Necrotizing Enterocolitis
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
JP2011526900A (ja) 2008-06-30 2011-10-20 イーエルシー マネージメント エルエルシー イソニコチンアミドを含む外用組成物
EP3330252B1 (en) * 2008-11-11 2020-02-12 Signum Biosciences, Inc. Isoprenyl compounds and methods thereof
US20130052162A1 (en) * 2010-04-20 2013-02-28 Cedars-Sinai Medical Center Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon
EP2522331A1 (en) * 2011-05-09 2012-11-14 DSM IP Assets B.V. Use of resveratrol and niacinamide
WO2013030794A2 (en) * 2011-08-31 2013-03-07 Behrooz Kasraee Use of substituted pyridines as skin depigmenting compounds
US20140161750A1 (en) * 2012-12-12 2014-06-12 Thomas Christopher Balshi Sunscreen composition with pigment correcting properties
EP2742942B1 (en) * 2012-12-14 2019-05-22 Unilever N.V. Niacinamide for inducing generation of antimicrobial peptides
EP3060311B1 (en) * 2013-10-24 2019-05-22 The Procter and Gamble Company Skin lightening cosmetic compositions and methods
BR112016024400A2 (pt) 2014-05-12 2017-08-15 Unilever Nv uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo
JP6880011B2 (ja) * 2015-10-05 2021-06-02 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚美白組成物

Also Published As

Publication number Publication date
CN108135824A (zh) 2018-06-08
WO2017060211A1 (en) 2017-04-13
US20200230045A1 (en) 2020-07-23
MX2018004143A (es) 2018-06-13
KR20180054647A (ko) 2018-05-24
AR106261A1 (es) 2017-12-27
CA3000880A1 (en) 2017-04-13
CN108135824B (zh) 2021-09-17
CA3000296A1 (en) 2017-04-13
PH12018500619A1 (en) 2018-10-01
EP3359124B1 (en) 2020-06-03
EP3359261A1 (en) 2018-08-15
EA035789B1 (ru) 2020-08-11
US20180296457A1 (en) 2018-10-18
KR102643373B1 (ko) 2024-03-07
US11298312B2 (en) 2022-04-12
MX365369B (es) 2019-05-31
EP3359261B1 (en) 2019-05-15
BR112018005742A2 (pt) 2018-10-09
JP2018529741A (ja) 2018-10-11
CN108136232A (zh) 2018-06-08
BR112018005742B1 (pt) 2021-11-16
JP2018529735A (ja) 2018-10-11
EA035440B1 (ru) 2020-06-15
ZA201802005B (en) 2019-07-31
ZA201802233B (en) 2019-07-31
JP6907196B2 (ja) 2021-07-21
CN108136232B (zh) 2021-08-13
WO2017060213A1 (en) 2017-04-13
US20180280278A1 (en) 2018-10-04
EA201890889A1 (ru) 2018-09-28
PH12018500619B1 (en) 2018-10-01
US10660840B2 (en) 2020-05-26
EP3359124A1 (en) 2018-08-15
US10952952B2 (en) 2021-03-23
JP6880011B2 (ja) 2021-06-02
MX2018004144A (es) 2018-06-13

Similar Documents

Publication Publication Date Title
EA201890886A1 (ru) Композиция для отбеливания кожи
EA202092590A1 (ru) Пиридазиноны в качестве ингибиторов parp7
MD3368541T2 (ro) Compoziții și procedee de inhibare a activității arginazei
UY36357A (es) Composiciones y métodos para la inhibición de la expresión génica de hao1 (hidroxiácido oxidasa 1 (glicolato oxidasa))
MX2016012123A (es) Composiciones para modular la expresion de ataxina 2.
UY35583A (es) COMPOSICIONES DE ARNi CONTRA TMPRSS6 Y MÉTODOS PARA SU USO
PH12019550076A1 (en) SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
EA201500954A1 (ru) Синергетические композиции, содержащие штамм bacillus subtilis и пестицид
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
EA202090183A1 (ru) Композиции, способы и получение дейтерированного домперидона
MX368814B (es) Composiciones que contienen azufre polimérico y usos de estas.
CY1123707T1 (el) Νεοι αναστολεις καλλικρεϊνης 7
PH12017501200A1 (en) A skin lightening composition comprising niacinamide and ilomastat
MX2017012610A (es) Composiciones y metodos para inhibir la expresion del gen lect2.
MX2018008971A (es) Composiciones de limpieza.
PH12017500996A1 (en) A skin lightening composition
MX2020001424A (es) Una composición para el cuidado personal.
GB2564990A (en) Topical compositions for neuropathic pain
NZ746011A (en) Glycoalkaloid combinations and various uses thereof
BR112017018828A2 (pt) peptídeo possuindo atividade de clareamento da pele e uso do mesmo
EA201792093A1 (ru) 2-тиопиримидиноны
MX2018000538A (es) Composicion antimicrobiana.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
MX370875B (es) Composición cosmética reductiva de aplicación tópica que contiene queratina y azufre.
FR3008315B1 (fr) Composition topique cosmetique protectrice vis-a-vis des xenobiotiques

Legal Events

Date Code Title Description
PC4A Registration of transfer of a eurasian patent by assignment
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM